Flinton Capital Management’s Q32 Bio QTTB Stock Holding History

Flinton Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$39K	Buy	+121	New	+$41.1K	﹤0.01%	836

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flinton Capital Management's QTTB Position: Q3 2019 in Review

Flinton Capital Management opened a new position in Q32 Bio (QTTB) in Q3 2019: 121 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings.

80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

Flinton Capital Management held 121 shares of Q32 Bio worth $39K as of Q3 2019.
Q32 Bio was a new Flinton Capital Management position in Q3 2019.
Q32 Bio made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #836 holding.
80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.